International Consensus for Provisions of Quality-Driven Care in Childhood-Onset Systemic Lupus Erythematosus

Authors


  • The contents of this study are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health or the Center for Clinical and Translational Science and Training.

Cincinnati Children's Hospital Medical Center, University of Cincinnati, MLC 4010, 3333 Burnet Avenue, Cincinnati, OH 45229-3039. E-mail: hermine.brunner@cchmc.org

Abstract

Objective

To obtain international consensus around processes that support the delivery of high-quality care to patients with childhood-onset systemic lupus erythematosus (SLE) based on current recommendations and scientific evidence.

Methods

To identify process quality indicators (QIs) for the medical care of children and adolescents with childhood-onset SLE, we sent 2 Delphi questionnaires internationally to 340 physicians who treat these patients. We set consensus at 80% of completed responses.

Results

Two hundred ninety-seven physicians (87%) responded to the first Delphi questionnaire and 265 physicians (76%) responded to the second questionnaire. The group achieved consensus for 26 QIs addressing laboratory testing at diagnosis, health maintenance measures, diagnosis and therapy of lupus nephritis, general preventive strategies, surveillance for medication safety, counseling and evaluation of cardiovascular risk factors, as well as transition planning. Of the 26 process QIs for use in childhood-onset SLE, 11 matched those established for adults with SLE, 9 required modification, and consensus was reached for an additional 6 QIs specific to children.

Conclusion

An international consensus for a set of process QIs for childhood-onset SLE was reached that considers unique aspects of children with childhood-onset SLE. The presented set of QIs for children and adolescents with childhood-onset SLE defines agreed-upon standards of medical care.

Ancillary